DihydrolicoisoflavoneCAS# 164163-92-2 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 164163-92-2 | SDF | Download SDF |
PubChem ID | 134715142 | Appearance | Powder |
Formula | C20H20O6 | M.Wt | 356.4 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3S)-3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-2,3-dihydrochromen-4-one | ||
SMILES | CC(=CCC1=C(C=CC(=C1O)C2COC3=CC(=CC(=C3C2=O)O)O)O)C | ||
Standard InChIKey | BAEYWOSUJSUYFI-CQSZACIVSA-N | ||
Standard InChI | InChI=1S/C20H20O6/c1-10(2)3-4-13-15(22)6-5-12(19(13)24)14-9-26-17-8-11(21)7-16(23)18(17)20(14)25/h3,5-8,14,21-24H,4,9H2,1-2H3/t14-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Dihydrolicoisoflavone A possesses weaker anti-H. pylori activity, it may be useful chemopreventive agents for peptic ulcer or gastric cancer in H. pylori-infected individuals. |
Targets | Antifection |
Dihydrolicoisoflavone Dilution Calculator
Dihydrolicoisoflavone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8058 mL | 14.0292 mL | 28.0584 mL | 56.1167 mL | 70.1459 mL |
5 mM | 0.5612 mL | 2.8058 mL | 5.6117 mL | 11.2233 mL | 14.0292 mL |
10 mM | 0.2806 mL | 1.4029 mL | 2.8058 mL | 5.6117 mL | 7.0146 mL |
50 mM | 0.0561 mL | 0.2806 mL | 0.5612 mL | 1.1223 mL | 1.4029 mL |
100 mM | 0.0281 mL | 0.1403 mL | 0.2806 mL | 0.5612 mL | 0.7015 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Kushenol S
Catalog No.:BCN8634
CAS No.:254886-72-1
- 2,3,4,5-Tetracaffeoyl-D-glucaric acid
Catalog No.:BCN8633
CAS No.:1419478-52-6
- Saikosaponin E
Catalog No.:BCN8632
CAS No.:64340-44-9
- 2-Amino-N-(2-bromophenyl)benzamide
Catalog No.:BCN8631
CAS No.:34489-85-5
- Glyasperin F
Catalog No.:BCN8630
CAS No.:145382-61-2
- Bacopaside V
Catalog No.:BCN8629
CAS No.:620592-16-7
- Saikosaponin G
Catalog No.:BCN8628
CAS No.:99365-19-2
- 17-Hydroxyisolathyrol
Catalog No.:BCN8627
CAS No.:93551-00-9
- Leonloside D
Catalog No.:BCN8626
CAS No.:20830-84-6
- Lucidenic acid E
Catalog No.:BCN8625
CAS No.:98665-17-9
- Seconeokadsuranic acid A
Catalog No.:BCN8624
CAS No.:124817-74-9
- Laetanine
Catalog No.:BCN8623
CAS No.:72361-67-2
- (Z)-Aldosecologanin
Catalog No.:BCN8636
CAS No.:82474-97-3
- Veratrosine
Catalog No.:BCN8637
CAS No.:475-00-3
- Bruceoside A
Catalog No.:BCN8638
CAS No.:63306-30-9
- Glabrone
Catalog No.:BCN8639
CAS No.:60008-02-8
- Hypaconine
Catalog No.:BCN8640
CAS No.:63238-68-6
- Lancifodilactone C
Catalog No.:BCN8641
CAS No.:663176-26-9
- Myrrhone
Catalog No.:BCN8642
CAS No.:183551-83-9
- Caesappanin C
Catalog No.:BCN8643
CAS No.:1913319-59-1
- (1S,2S)-threo-Honokitriol
Catalog No.:BCN8644
CAS No.:1099687-80-5
- 1''-O-beta-D-glucopyranosylformoside
Catalog No.:BCN8645
CAS No.:148245-77-6
- 14,15beta-Dihydroxyklaineanone
Catalog No.:BCN8646
CAS No.:137359-82-1
- Nephthenol
Catalog No.:BCN8647
CAS No.:53915-41-6
Dihydrolicoisoflavone, a new isoflavanone from Swartzia polyphylla.[Pubmed:7623042]
J Nat Prod. 1995 Apr;58(4):629-32.
Fractionation of an ethanolic extract of Swartzia polyphylla, guided in part by an assay for inhibition of protein kinase C, led to the isolation of the known flavonoids biochanin A, dihydrobiochanin A, ferreirin, dalbergioidin, and naringenin, and one new prenylated isoflavonone, Dihydrolicoisoflavone [1].
Anti-Helicobacter pylori flavonoids from licorice extract.[Pubmed:12127165]
Life Sci. 2002 Aug 9;71(12):1449-63.
Licorice is the most used crude drug in Kampo medicines (traditional Chinese medicines modified in Japan). The extract of the medicinal plant is also used as the basis of anti-ulcer medicines for treatment of peptic ulcer. Among the chemical constituents of the plant, glabridin and glabrene (components of Glycyrrhiza glabra), licochalcone A (G. inflata), licoricidin and licoisoflavone B (G. uralensis) exhibited inhibitory activity against the growth of Helicobacter pylori in vitro. These flavonoids also showed anti-H. pylori activity against a clarithromycin (CLAR) and amoxicillin (AMOX)-resistant strain. We also investigated the methanol extract of G. uralensis. From the extract, three new isoflavonoids (3-arylcoumarin, pterocarpan, and isoflavan) with a pyran ring, gancaonols A[bond]C, were isolated together with 15 known flavonoids. Among these compounds, vestitol, licoricone, 1-methoxyphaseollidin and gancaonol C exhibited anti-H. pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains. Glycyrin, formononetin, isolicoflavonol, glyasperin D, 6,8-diprenylorobol, gancaonin I, Dihydrolicoisoflavone A, and gancaonol B possessed weaker anti-H. pylori activity. These compounds may be useful chemopreventive agents for peptic ulcer or gastric cancer in H. pylori-infected individuals.